Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for prevention of post-ERCP pancreatitis
NCT02992652Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of allopurinol in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Ain Shams University. Primary endpoint: Diagnosis of procedure-related pancreatitis at 24 hours. Started Jan 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT02992652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992652.